Zantac maker settles 4,000 lawsuits linking discontinued heartburn drug to cancers

Sanofi, drugmaker behind discontinued heartburn medication Zantac, has agreed to settle 4,000 lawsuits alleging that the drug contained the ‘probable human carcinogen’ NDMA. (Source: the Mail online | Health)